Table 3. Participation according to Baseline characteristics of participants of the PSMAR breast cancer screening program in the BHA affected by the COVID-19 pandemic in the area of reference of Parc de Salut Mar (PSMAR), in Barcelona, Spain in the period 2012–2021 by screening round.
|
Pre-COVID 4 round | Pre-COVID 3 round | Pre-COVID 2 round | Pre-COVID 1 round | Pre-COVID total | Post-COVID +1 round | Difference post–pre | p valor | |||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
(2012–2013) | (2014–2015) | (2016–2017) | (2018–2019) | (2012–2019) | (2020–2021) | ||||||||||
n | % | n | % | n | % | n | % | n | % | n | % | ||||
Age group | 50–54 | 4550 | 49.98 | 4596 | 48.40 | 4546 | 48.10 | 4434 | 49.20 | 18,126 | 48.91 | 4073 | 46.59 | −2.32% | <0.001* |
55–59 | 3912 | 54.69 | 3901 | 53.11 | 3985 | 52.65 | 4089 | 53.58 | 15,887 | 53.50 | 4038 | 51.12 | −2.37% | <0.001* | |
60–64 | 3784 | 56.59 | 3729 | 56.73 | 3710 | 55.44 | 3780 | 56.71 | 15,003 | 56.36 | 3664 | 53.64 | −2.73% | <0.001* | |
65–70 | 3325 | 58.46 | 3352 | 58.23 | 3225 | 57.66 | 3220 | 59.77 | 13,122 | 58.52 | 3020 | 54.87 | −3.65% | <0.001* | |
Socioeconomic index level | Low | 3282 | 73.62 | 3223 | 72.07 | 3201 | 73.23 | 3226 | 73.80 | 12,932 | 73.18 | 3065 | 67.57 | −5.61% | <0.001* |
Middle-low | 1603 | 69.60 | 1612 | 68.42 | 1620 | 69.56 | 1630 | 69.72 | 6465 | 69.32 | 1586 | 63.29 | −6.03% | <0.001* | |
Middle-high | 8363 | 54.99 | 8537 | 54.49 | 8508 | 53.63 | 8626 | 55.45 | 34,034 | 54.63 | 8164 | 52.33 | −2.30% | <0.001* | |
High | 2323 | 34.87 | 2206 | 33.06 | 2137 | 31.70 | 2041 | 31.74 | 8707 | 32.85 | 1981 | 31.27 | −1.58% | 0.016* | |
Type of screening | |||||||||||||||
Prevalent | First invitation | 2058 | 46.68 | 1957 | 42.81 | 1876 | 43.92 | 1850 | 48.29 | 7741 | 45.32 | 2133 | 41.71 | −3.61% | <0.001* |
Previous nonparticipant | 812 | 9.56 | 771 | 8.92 | 750 | 8.29 | 763 | 8.47 | 3096 | 8.80 | 802 | 9.48 | 0.69% | 0.05* | |
Total | 2870 | 22.24 | 2728 | 20.65 | 2626 | 19.71 | 2613 | 20.35 | 10,837 | 20.73 | 2935 | 21.63 | 0.90% | 0.024* | |
Incident | Regular participant | 12,003 | 89.51 | 12,116 | 89.89 | 12,095 | 89.63 | 12,098 | 90.35 | 48,312 | 89.84 | 11,166 | 85.43 | −4.41% | <0.001* |
Irregular participant | 698 | 30.15 | 734 | 29.58 | 745 | 29.92 | 812 | 32.95 | 2989 | 30.66 | 695 | 29.74 | −0.92% | 0.38 | |
Total | 12,701 | 80.77 | 12,850 | 80.52 | 12,840 | 80.33 | 12,910 | 81.43 | 51,301 | 80.76 | 11,861 | 76.98 | −3.78% | <0.001* | |
Total | 15,571 | 54.39 | 15,578 | 53.41 | 15,466 | 52.78 | 15,523 | 54.09 | 62,138 | 53.66 | 14,795 | 51.06 | −2.60% | <0.001* |
Pre-COVID totals calculated as the sum of the four pre-COVID screening rounds. Percentages show the proportion of participants among women invited for each category. p values obtained with chi-square test comparing the total pre- and post-COVID proportions. * indicates statistical significance, with a p-value < of equal to 0.05.